Consider the following situation.
Two randomised, controlled trials for a new drug, Curit, are conducted in two different population groups of patients at a risk of a heart attack, over a period of 10 years.
The first trial is conducted in a group of 100 patients who have several risk factors for a heart attack and are classed as having a high baseline risk.
Without treatment, 90 patients out of 100 will experience a heart attack over the next 10 years. The control event rate (CER) is 90%.
With Curit, the number of high risk patients who will experience a heart attack over the next 10 years falls to 60 patients out of 100. The experimental event rate (EER) is 60%
We can present the magnitude of effect with Curit in one of two ways:
Click the button on the media player, or click the banners above to move to part 4.